Micron Technology (MU) 10-Q 29 Mar 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Mar. 02, 2023	Mar. 23, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 02, 2023
Document Transition Report	false
Entity File Number	1-10658
Entity Registrant Name	Micron Technology, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-1618004
Entity Address, Address Line One	8000 S. Federal Way
Entity Address, City or Town	Boise
Entity Address, State or Province	ID
Entity Address, Postal Zip Code	83716
City Area Code	208
Local Phone Number	368-4000
Title of 12(b) Security	Common Stock, par value $0.10 per share
Trading Symbol	MU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,094,394,354
Entity Central Index Key	0000723125
Current Fiscal Year End Date	--08-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022
Income Statement [Abstract]
Revenue	$ 3,693	$ 7,786	$ 7,778	$ 15,473
Cost of goods sold	4,899	4,110	8,091	8,232
Gross margin	(1,206)	3,676	(313)	7,241
Research and development	788	792	1,637	1,504
Selling, general, and administrative	231	263	482	522
Restructure and asset impairments	86	5	99	43
Other operating (income) expense, net	(8)	70	(19)	(5)
Operating income (loss)	(2,303)	2,546	(2,512)	5,177
Interest income	119	12	207	22
Interest expense	(89)	(55)	(140)	(100)
Other non-operating income (expense), net	2	6	(2)	(69)
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees	(2,271)	2,509	(2,447)	5,030
Income tax (provision) benefit	(54)	(255)	(62)	(474)
Equity in net income (loss) of equity method investees	13	9	2	13
Net income (loss)	$ (2,312)	$ 2,263	$ (2,507)	$ 4,569
Earnings (loss) per share
Basic (in dollars per share)	$ (2.12)	$ 2.02	$ (2.30)	$ 4.08
Diluted (in dollars per share)	$ (2.12)	$ 2	$ (2.30)	$ 4.04
Number of shares used in per share calculations
Basic (in shares)	1,091	1,119	1,091	1,119
Diluted (in shares)	1,091	1,130	1,091	1,130

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (2,312)	$ 2,263	$ (2,507)	$ 4,569
Other comprehensive income (loss), net of tax
Gains (losses) on derivative instruments	92	(34)	200	(120)
Gains (losses) on investments	7	(13)	(12)	(20)
Foreign currency translation adjustments	1	1	(2)	1
Pension liability adjustments	0	(1)	1	(1)
Other comprehensive income (loss)	100	(47)	187	(140)
Total comprehensive income (loss)	$ (2,212)	$ 2,216	$ (2,320)	$ 4,429

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Mar. 02, 2023	Sep. 01, 2022
Assets
Cash and equivalents		$ 9,798	$ 8,262
Short-term investments		1,020	1,069
Receivables		2,278	5,130
Inventories		8,129	6,663
Other current assets		673	657
Total current assets		21,898	21,781
Long-term marketable investments	[1]	1,212	1,647
Property, plant, and equipment		39,085	38,549
Operating lease right-of-use assets		673	678
Intangible assets		410	421
Deferred tax assets		697	702
Goodwill		1,228	1,228
Other noncurrent assets		1,317	1,277
Total assets		66,520	66,283
Liabilities and equity
Accounts payable and accrued expenses		4,310	6,090
Current debt		237	103
Other current liabilities		708	1,346
Total current liabilities		5,255	7,539
Long-term debt		12,037	6,803
Noncurrent operating lease liabilities		610	610
Noncurrent unearned government incentives		529	589
Other noncurrent liabilities		832	835
Total liabilities		19,263	16,376
Commitments and contingencies
Shareholders’ equity
Common stock, $0.10 par value, 3,000 shares authorized, 1,235 shares issued and 1,094 outstanding (1,226 shares issued and 1,094 outstanding as of September 1, 2022)		123	123
Additional capital		10,633	10,197
Retained earnings		44,426	47,274
Treasury stock, 141 shares held (132 shares as of September 1, 2022)		(7,552)	(7,127)
Accumulated other comprehensive income (loss)		(373)	(560)
Total equity		47,257	49,907
Total liabilities and equity		$ 66,520	$ 66,283
[1] The maturities of long-term marketable securities primarily range from one four years.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Mar. 02, 2023	Sep. 01, 2022
Shareholders’ equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,235	1,226
Common Stock, outstanding (in shares)	1,094	1,094
Treasury Stock, held (in shares)	141	132

STATEMENT OF CHANGES IN EQUITY

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Sep. 02, 2021		1,216
Balance of total equity at Sep. 02, 2021	$ 43,933	$ 122	$ 9,453	$ 39,051	$ (4,695)	$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,306			2,306
Other comprehensive income (loss), net	(93)					(93)
Stock issued under stock plans (in shares)		5
Stock issued under stock plans	5	$ 0	5
Stock-based compensation expense	118		118
Repurchase of stock - repurchase program	(259)				(259)
Repurchase of stock - withholdings on employee equity awards (in shares)		(1)
Repurchase of stock - withholdings on employee equity awards	(102)	$ 0	(12)	(90)
Balance (in shares) at Dec. 02, 2021		1,220
Balance of total equity at Dec. 02, 2021	45,908	$ 122	9,564	41,267	(4,954)	(91)
Balance (in shares) at Sep. 02, 2021		1,216
Balance of total equity at Sep. 02, 2021	43,933	$ 122	9,453	39,051	(4,695)	2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,569
Other comprehensive income (loss), net	(140)
Balance (in shares) at Mar. 03, 2022		1,223
Balance of total equity at Mar. 03, 2022	47,845	$ 122	9,816	43,407	(5,362)	(138)
Balance (in shares) at Dec. 02, 2021		1,220
Balance of total equity at Dec. 02, 2021	45,908	$ 122	9,564	41,267	(4,954)	(91)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,263			2,263
Other comprehensive income (loss), net	(47)					(47)
Stock issued under stock plans (in shares)		4
Stock issued under stock plans	124	$ 0	124
Stock-based compensation expense	129		129
Repurchase of stock - repurchase program	(408)				(408)
Repurchase of stock - withholdings on employee equity awards (in shares)		(1)
Repurchase of stock - withholdings on employee equity awards	$ (11)	$ 0	(1)	(10)
Cash dividends declared (per share)	$ 0.10
Dividends and dividend equivalents declared	$ (113)			(113)
Balance (in shares) at Mar. 03, 2022		1,223
Balance of total equity at Mar. 03, 2022	$ 47,845	$ 122	9,816	43,407	(5,362)	(138)
Balance (in shares) at Sep. 01, 2022	1,226	1,226
Balance of total equity at Sep. 01, 2022	$ 49,907	$ 123	10,197	47,274	(7,127)	(560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(195)			(195)
Other comprehensive income (loss), net	87					87
Stock issued under stock plans (in shares)		8
Stock issued under stock plans	7	$ 0	7
Stock-based compensation expense	146		146
Repurchase of stock - repurchase program	(425)				(425)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (95)	$ 0	(15)	(80)
Cash dividends declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (126)			(126)
Balance (in shares) at Dec. 01, 2022		1,232
Balance of total equity at Dec. 01, 2022	$ 49,306	$ 123	10,335	46,873	(7,552)	(473)
Balance (in shares) at Sep. 01, 2022	1,226	1,226
Balance of total equity at Sep. 01, 2022	$ 49,907	$ 123	10,197	47,274	(7,127)	(560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,507)
Other comprehensive income (loss), net	$ 187
Balance (in shares) at Mar. 02, 2023	1,235	1,235
Balance of total equity at Mar. 02, 2023	$ 47,257	$ 123	10,633	44,426	(7,552)	(373)
Balance (in shares) at Dec. 01, 2022		1,232
Balance of total equity at Dec. 01, 2022	49,306	$ 123	10,335	46,873	(7,552)	(473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,312)			(2,312)
Other comprehensive income (loss), net	100					100
Stock issued under stock plans (in shares)		3
Stock issued under stock plans	142	$ 0	142
Stock-based compensation expense	157		157
Repurchase of stock - withholdings on employee equity awards (in shares)		0
Repurchase of stock - withholdings on employee equity awards	$ (8)	$ 0	(1)	(7)
Cash dividends declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (128)			(128)
Balance (in shares) at Mar. 02, 2023	1,235	1,235
Balance of total equity at Mar. 02, 2023	$ 47,257	$ 123	$ 10,633	$ 44,426	$ (7,552)	$ (373)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022
Cash flows from operating activities
Net income (loss)	$ (2,507)	$ 4,569
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	3,863	3,413
Provision to write-down inventories to net realizable value	1,430	0
Stock-based compensation	303	247
(Gain) loss on debt repurchases	0	83
Change in operating assets and liabilities:
Receivables	2,910	(44)
Inventories	(2,896)	(900)
Accounts payable and accrued expenses	(1,795)	107
Other	(22)	91
Net cash provided by operating activities	1,286	7,566
Cash flows from investing activities
Expenditures for property, plant, and equipment	(4,654)	(5,876)
Purchases of available-for-sale securities	(293)	(922)
Proceeds from maturities of available-for-sale securities	765	631
Proceeds from government incentives	64	66
Proceeds from sales of available-for-sale securities	8	172
Proceeds from sale of Lehi, Utah fab	0	893
Other	(71)	(140)
Net cash provided by (used for) investing activities	(4,181)	(5,176)
Cash flows from financing activities
Proceeds from issuance of debt	5,221	2,000
Repurchases of common stock - repurchase program	(425)	(667)
Payments of dividends to shareholders	(252)	(224)
Payments on equipment purchase contracts	(76)	(105)
Repayments of debt	(53)	(1,981)
Other	19	(2)
Net cash provided by (used for) financing activities	4,434	(979)
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	9	(16)
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,548	1,395
Cash, cash equivalents, and restricted cash at beginning of period	8,339	7,829
Cash, cash equivalents, and restricted cash at end of period	$ 9,887	$ 9,224

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Mar. 02, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies For a discussion of our significant accounting policies, see “Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended September 1, 2022. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended September 1, 2022. Basis of Presentation The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended September 1, 2022. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2023 and 2022 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended September 1, 2022.

Cash and Investments

Cash and Investments	6 Months Ended
	Mar. 02, 2023
Investments and Cash [Abstract]
Cash and Investments	Cash and Investments All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: March 2, 2023 September 1, 2022 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,222 $ — $ — $ 6,222 $ 6,055 $ — $ — $ 6,055 Level 1 (2) Money market funds 1,893 — — 1,893 1,196 — — 1,196 Level 2 (3) Certificates of deposit 1,654 61 — 1,715 976 50 — 1,026 Corporate bonds 10 761 700 1,471 — 759 995 1,754 Asset-backed securities — 13 475 488 — 20 608 628 Government securities 10 101 37 148 2 155 44 201 Commercial paper 9 84 — 93 33 85 — 118 9,798 $ 1,020 $ 1,212 $ 12,030 8,262 $ 1,069 $ 1,647 $ 10,978 Restricted cash (4) 89 77 Cash, cash equivalents, and restricted cash $ 9,887 $ 8,339 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of March 2, 2023 or September 1, 2022. (4) Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions or which will be returned if performance conditions are not met. Gross realized gains and losses from sales of available-for-sale securities were not significant for any period presented. Non-marketable Equity Investments In addition to the amounts included in the table above, we had $218 million and $222 million of non-marketable equity investments without a readily determinable fair value that were included in other noncurrent assets as of March 2, 2023 and September 1, 2022, respectively.

Receivables

Receivables	6 Months Ended
	Mar. 02, 2023
Receivables [Abstract]
Receivables	Receivables As of March 2, September 1, Trade receivables $ 1,891 $ 4,765 Income and other taxes 215 251 Other 172 114 $ 2,278 $ 5,130

Inventories

Inventories	6 Months Ended
	Mar. 02, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories As of March 2, September 1, Finished goods $ 1,631 $ 1,028 Work in process 5,653 4,830 Raw materials and supplies 845 805 $ 8,129 $ 6,663 In the second quarter of 2023, we recorded a charge of $1.43 billion to cost of goods sold to write down the carrying value of work in process and finished goods inventories to their estimated net realizable values.

Property, Plant, and Equipment

Property, Plant, and Equipment	6 Months Ended
	Mar. 02, 2023
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Property, Plant, and Equipment As of March 2, September 1, Land $ 279 $ 280 Buildings 17,401 16,676 Equipment (1) 64,279 61,354 Construction in progress (2) 2,093 1,897 Software 1,247 1,124 85,299 81,331 Accumulated depreciation (46,214) (42,782) $ 39,085 $ 38,549 (1) Includes costs related to equipment not placed into service of $3.43 billion as of March 2, 2023 and $3.35 billion as of September 1, 2022. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets

Intangible Assets	6 Months Ended
	Mar. 02, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure	Intangible Assets March 2, 2023 September 1, 2022 As of Gross Accumulated Net Carrying Gross Accumulated Net Carrying Product and process technology $ 740 $ (330) $ 410 $ 742 $ (321) $ 421 In the first six months of 2023 and 2022, we capitalized $51 million and $105 million, respectively, for product and process technology with weighted-average useful lives of 10 years, and 7 years, respectively. Amortization expense was $45 million and $40 million for the first six months of 2023 and 2022, respectively. Expected amortization expense is $42 million for the remainder of 2023, $73 million for 2024, $52 million for 2025, $46 million for 2026, and $40 million for 2027.

Leases

Leases	6 Months Ended
	Mar. 02, 2023
Leases [Abstract]
Leases, Finance	Leases The components of lease cost are presented below: Quarter ended Six months ended March 2, March 3, March 2, March 3, Finance lease cost Amortization of right-of-use assets $ 25 $ 27 $ 49 $ 52 Interest on lease liabilities 6 6 12 12 Operating lease cost (1) 31 30 67 59 $ 62 $ 63 $ 128 $ 123 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: Six months ended March 2, March 3, Cash flows used for operating activities Finance leases $ 11 $ 11 Operating leases 60 56 Cash flows used for financing activities – Finance leases 53 52 Noncash acquisitions of right-of-use assets Finance leases 225 304 Operating leases 35 68 Supplemental balance sheet information related to leases was as follows: As of March 2, September 1, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,084 $ 904 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 60 Weighted-average remaining lease term (in years) Finance leases 10 12 Operating leases 11 12 Weighted-average discount rate Finance leases 2.40 % 2.65 % Operating leases 3.06 % 2.90 % As of March 2, 2023, maturities of lease liabilities by fiscal year were as follows: For the year ending Finance Leases Operating Leases Remainder of 2023 $ 78 $ 13 2024 152 73 2025 138 73 2026 129 72 2027 126 72 2028 and thereafter 619 524 Less imputed interest (171) (156) $ 1,071 $ 671 The table above excludes obligations for leases that have been executed but have not yet commenced. As of March 2, 2023, excluded obligations consisted of $195 million of estimated finance lease payments over a weighted-average period of 11 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.
Leases, Operating	Leases The components of lease cost are presented below: Quarter ended Six months ended March 2, March 3, March 2, March 3, Finance lease cost Amortization of right-of-use assets $ 25 $ 27 $ 49 $ 52 Interest on lease liabilities 6 6 12 12 Operating lease cost (1) 31 30 67 59 $ 62 $ 63 $ 128 $ 123 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: Six months ended March 2, March 3, Cash flows used for operating activities Finance leases $ 11 $ 11 Operating leases 60 56 Cash flows used for financing activities – Finance leases 53 52 Noncash acquisitions of right-of-use assets Finance leases 225 304 Operating leases 35 68 Supplemental balance sheet information related to leases was as follows: As of March 2, September 1, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,084 $ 904 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 60 Weighted-average remaining lease term (in years) Finance leases 10 12 Operating leases 11 12 Weighted-average discount rate Finance leases 2.40 % 2.65 % Operating leases 3.06 % 2.90 % As of March 2, 2023, maturities of lease liabilities by fiscal year were as follows: For the year ending Finance Leases Operating Leases Remainder of 2023 $ 78 $ 13 2024 152 73 2025 138 73 2026 129 72 2027 126 72 2028 and thereafter 619 524 Less imputed interest (171) (156) $ 1,071 $ 671 The table above excludes obligations for leases that have been executed but have not yet commenced. As of March 2, 2023, excluded obligations consisted of $195 million of estimated finance lease payments over a weighted-average period of 11 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	6 Months Ended
	Mar. 02, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses As of March 2, September 1, Accounts payable $ 1,689 $ 2,142 Property, plant, and equipment 1,712 2,170 Salaries, wages, and benefits 320 877 Income and other taxes 241 420 Other 348 481 $ 4,310 $ 6,090

Debt

Debt	6 Months Ended
	Mar. 02, 2023
Debt Disclosure [Abstract]
Debt	Debt March 2, 2023 September 1, 2022 Net Carrying Amount Net Carrying Amount As of Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total 2024 Term Loan A 5.340 % 5.38 % $ — $ 1,187 $ 1,187 $ — $ 1,187 $ 1,187 2025 Term Loan A 5.968 % 6.10 % — 1,050 1,050 — — — 2026 Term Loan A 6.093 % 6.23 % 49 946 995 — — — 2027 Term Loan A 6.218 % 6.36 % 57 1,092 1,149 — — — 2026 Notes 4.975 % 5.07 % — 499 499 — 498 498 2027 Notes (1) 4.185 % 4.27 % — 783 783 — 806 806 2029 A Notes 5.327 % 5.40 % — 697 697 — 697 697 2029 B Notes 6.750 % 6.54 % — 1,264 1,264 — — — 2030 Notes 4.663 % 4.73 % — 846 846 — 846 846 2032 Green Bonds 2.703 % 2.77 % — 995 995 — 994 994 2033 Notes 5.875 % 5.96 % — 745 745 — — — 2041 Notes 3.366 % 3.41 % — 497 497 — 496 496 2051 Notes 3.477 % 3.52 % — 496 496 — 496 496 Finance lease obligations N/A 2.40 % 131 940 1,071 103 783 886 $ 237 $ 12,037 $ 12,274 $ 103 $ 6,803 $ 6,906 (1) In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, as a result, the carrying values of our 2027 Notes reflect adjustments in fair value. Debt Activity The table below presents the effects of debt financing activities in the first six months of 2023. Increase in Principal Increase in Carrying Value Increase in Cash 2025 Term Loan A $ 1,052 $ 1,050 $ 1,050 2026 Term Loan A 996 994 994 2027 Term Loan A 1,152 1,149 1,149 2029 B Notes 1,250 1,264 1,264 2033 Notes 750 745 745 $ 5,200 $ 5,202 $ 5,202 Term Loan Agreements On November 3, 2022, we entered into a term loan agreement consisting of three tranches and borrowed $2.60 billion in aggregate principal amount, including $927 million due November 3, 2025; $746 million due November 3, 2026; and $927 million due November 3, 2027 (the “Term Loan Agreement”). We incurred aggregate fees of $6 million in connection with these borrowings. On January 5, 2023, we amended the Term Loan Agreement and borrowed an additional $600 million in aggregate principal amount, including $125 million due November 3, 2025, $250 million due November 3, 2026, and $225 million due November 3, 2027. The additional borrowings have terms that are identical to, and will be treated as a single class with, the three original tranches. The 2026 Term Loan A and 2027 Term Loan A each require equal quarterly installment payments in an amount equal to 1.25% of the original principal amount. The 2025 Term Loan A does not require quarterly installment payments. Borrowings under the Term Loan Agreement will generally bear interest at adjusted term SOFR plus an applicable interest rate margin ranging from 1.00% to 2.00%, varying by tranche and depending on our corporate credit ratings. The Term Loan Agreement requires us to maintain, on a consolidated basis, a leverage ratio of total indebtedness to adjusted EBITDA, as defined in the Term Loan Agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, except as described below. On March 27, 2023, we further amended the Term Loan Agreement to provide that in lieu of the foregoing leverage ratio, during the fourth quarter of 2023 and each quarter of 2024, we will be required to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Term Loan Agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, or alternatively, for up to three of such five quarters, we may elect to comply with a requirement of minimum liquidity, as defined in the Term Loan Agreement, of not less than $5.0 billion. Each of the leverage ratio and net leverage ratio maximums, as applicable, is subject to a temporary four quarter increase in such ratio to 3.75 to 1.00 following certain material acquisitions. Our obligations under the Term Loan Agreement are unsecured. On March 27, 2023, we also amended the agreement governing the 2024 Term Loan A to align the leverage ratio covenant with the corresponding covenant in the Term Loan Agreement described above. 2029 B Notes and 2033 Notes On October 31, 2022, we issued $750 million principal amount of senior unsecured 2029 B Notes in a public offering. The 2029 B Notes bear interest at a rate of 6.750% per year and will mature on November 1, 2029. Issuance costs and debt discount for these notes were $6 million. On February 9, 2023, we issued an additional $500 million principal amount of 2029 B Notes at a $22 million premium. The additional notes have terms that are identical to the terms of the original 2029 B Notes other than the original offering price. Also on February 9, 2023, we issued $750 million principal amount of senior unsecured 2033 Notes. The 2033 Notes bear interest at a rate of 5.875% per year and will mature on February 9, 2033. Aggregate issuance costs for the February 9, 2023 offerings were $7 million. We may redeem the 2029 B Notes and the 2033 Notes (the “Notes”), in whole or in part, at our option prior to their maturity dates at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed and (ii) the present value of the remaining scheduled payments of principal and interest, plus accrued interest in each case. We may also redeem the Notes, in whole or in part, at a price equal to par either two or three months prior to maturity in accordance with the terms of the Notes. The Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing such notes) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event occurs, as defined in the indenture governing the Notes, we will be required to offer to purchase such notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date. Revolving Credit Facility As of March 2, 2023, $2.50 billion was available to us under the Revolving Credit Facility and no amounts were outstanding. Any amounts outstanding under the Revolving Credit Facility would mature in May 2026 and amounts borrowed may be prepaid any time without penalty. Any amounts drawn under the Revolving Credit Facility would generally bear interest at a rate equal to LIBOR plus 1.00% to 1.75%, depending on our corporate credit ratings. The credit facility agreement provides for a transition to SOFR or other alternate benchmark rate upon the retirement of LIBOR in 2023. On March 27, 2023, we amended the agreement governing the Revolving Credit Facility to align the leverage ratio covenant with the corresponding covenants in the Term Loan Agreement and 2024 Term Loan A described above. Maturities of Notes Payable As of March 2, 2023, maturities of notes payable by fiscal year were as follows: Remainder of 2023 $ 54 2024 107 2025 1,295 2026 1,659 2027 1,780 2028 and thereafter 6,443 Unamortized issuance costs, discounts, and premium, net (21) Hedge accounting fair value adjustment (114) $ 11,203

Commitments

Commitments	6 Months Ended
	Mar. 02, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments In the second quarter of 2023, we entered into an 18-year power purchase agreement in Singapore to purchase up to 450 megawatts of power at variable prices. This contract, which begins in the fourth quarter of 2023, is expected to supply the majority of our power consumption needs in Singapore with more favorable pricing than our existing supply arrangements.

Contingencies

Contingencies	6 Months Ended
	Mar. 02, 2023
Loss Contingency [Abstract]
Contingencies	Contingencies We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. (“MXA”) was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. (“Jinhua”) in the Fuzhou Intermediate People’s Court in Fujian Province, China (the “Fuzhou Court”). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. (“MSS”) was served with the same complaint. The complaint alleges that MXA and MSS infringed one Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation (“UMC”) in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringed one Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 90 million Chinese yuan plus court fees incurred. On November 26, 2021, pursuant to a settlement agreement between UMC and Micron, UMC filed an application to the Fuzhou Court to withdraw its complaints against MXA and MSS. On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and an additional complaint filed by UMC in the Fuzhou Court. The additional complaints allege that MSS infringes two Chinese patents by manufacturing and selling certain Crucial MX300 SSDs. The complaint filed by UMC seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On November 26, 2021, pursuant to a settlement agreement between UMC and Micron, UMC filed an application to the Fuzhou Court to withdraw its complaint against MSS. On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistix-branded DRAM modules and solid-state drives in China. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision. On May 4, 2020, Flash-Control, LLC filed a patent infringement action against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that four U.S. patents are infringed by unspecified DDR4 SDRAM, NVRDIMM, NVDIMM, 3D XPoint, and/or SSD products that incorporate memory controllers and flash memory. The complaint seeks damages, attorneys’ fees, and costs. On July 21, 2020, in a separate matter, the District Court ruled that two of the four asserted patents are invalid, and on July 14, 2021, the U.S. Court of Appeals for the Federal Circuit affirmed the ruling of invalidity. On April 28, 2021, Netlist, Inc. (“Netlist”) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. (“MSP”), and Micron Technology Texas, LLC (“MTEC”) in the U.S. District Court for the Western District of Texas. The first complaint alleges that one U.S. patent is infringed by certain of our non-volatile dual in-line memory modules. The second complaint alleges that three U.S. patents are infringed by certain of our load-reduced dual in-line memory modules (“LRDIMMs”). Each complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor Germany, GmbH in Dusseldorf Regional Court alleging that two German patents are infringed by certain of our LRDIMMs. The complaint seeks damages, costs, and injunctive relief. On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. On August 1, 2022, Netlist filed a second patent infringement complaint against the same defendants in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. On August 15, 2022, Netlist amended the second complaint to assert that two additional U.S. patents are infringed by certain of our LRDIMMs. The complaints in E.D. Tex. seek injunctive relief, damages, and attorneys’ fees. On May 10, 2021, Vervain, LLC filed a patent infringement action against Micron, MSP, and MTEC in the U.S. District Court for the Western District of Texas. The complaint alleges that four U.S. patents are infringed by certain SSD products. The complaint seeks injunctive relief, damages, attorneys’ fees, and costs. Between April 27, 2022 and October 18, 2022, Bell Semiconductor, LLC (“Bell”) filed four patent infringement complaints against Micron in the U.S. District Court for the District of Idaho. These complaints allege that a total of six U.S. patents are infringed by certain SSDs, a process for designing a NAND flash device included in certain SSDs, and an SSD controller. On September 30, 2022, Bell filed a complaint against Micron in the U.S. District Court for the District of Delaware alleging that six U.S. patents are infringed by certain SSD, GDDR5, GDDR6, GDDR6X, and DDR3 SDRAM products. Each of Bell’s complaints in the District Courts sought damages, injunctive relief, attorneys’ fees, and costs. On October 6, 2022, Bell filed a complaint with the ITC alleging violations of Section 337 of the Tariff Act of 1930 based on alleged importation of certain SSDs that infringe two U.S. patents also asserted by Bell in two of the lawsuits pending in the District of Idaho. The complaint requested institution of an investigation, which was granted on November 8, 2022, and, after the investigation, issuance of a limited exclusion order and cease and desist orders prohibiting Micron from importing, selling, offering for sale, or marketing the accused products in the United States. Pursuant to a December 31, 2022 agreement, all of Bell’s complaints against Micron have been dismissed, and the ITC investigation was dismissed as to Micron. On August 16, 2022, Sonrai Memory Ltd. filed a patent infringement action against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that two U.S. patents are infringed by certain SSD and NAND flash products. The complaint seeks damages, attorneys’ fees, and costs. On January 23, 2023, Besang Inc. filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas. The complaint alleges that one U.S. patent is infringed by certain of our 3D NAND and SSD products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda’s insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V. (“Micron B.V.”), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda’s shares of Inotera (the “Inotera Shares”), representing approximately 18% of Inotera’s outstanding shares at that time, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda’s claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda’s obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments had no immediate, enforceable effect and Micron, accordingly, has been able to continue to operate with full control of the Inotera Shares subject to further developments in the case. Micron and Micron B.V. appealed the judgments to the German Appeals Court, which thereafter appointed an independent expert to perform an evaluation of Dr. Jaffé’s claims that the amount Micron paid for Qimonda was less than fair market value. On March 31, 2020, the expert presented an opinion to the Appeals Court concluding that the amount paid by Micron was within an acceptable range of fair value. On October 5, 2022, the Appeals Court ruled that the relevant issue to be addressed is whether Qimonda's creditors were prejudiced such that the original transaction should be voided. The Appeals Court set a date of May 23, 2023 for issuing a decision. Antitrust Matters Six cases have been filed against Micron alleging price fixing of DRAM products in the following Canadian courts on the dates indicated: Superior Court of Quebec (April 30, 2018 and May 3, 2018), the Federal Court of Canada (May 2, 2018), the Ontario Superior Court of Justice (May 15, 2018), and the Supreme Court of British Columbia (May 10, 2018). The plaintiffs in these cases are individuals seeking certification of class actions on behalf of direct and indirect purchasers of DRAM in Canada (or regions of Canada) between June 1, 2016 and February 1, 2018. On May 15, 2018, the Chinese State Administration for Market Regulation (“SAMR”) notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Securities Matters On February 9, 2021, a derivative complaint was filed by a shareholder against Sanjay Mehrotra and other current and former directors of Micron, allegedly on behalf of and for the benefit of Micron, in the U.S. District Court for the District of Delaware alleging violations of securities laws, breaches of fiduciary duties, and other violations of law involving allegedly false and misleading statements about Micron’s commitment to diversity and progress in diversifying its workforce, executive leadership, and Board of Directors. The complaint seeks damages, fees, interest, costs, and an order requiring Micron to take various actions to allegedly improve its corporate governance and internal procedures. Other Matters In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. Contingency Assessment We are unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Equity

Equity	3 Months Ended
	Mar. 02, 2023
Equity [Abstract]
Equity	Equity Common Stock Repurchases : Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions and our ongoing determination of the best use of available cash. No shares were repurchased in the second quarter of 2023. In the first quarter of 2023, we repurchased 8.6 million shares of our common stock for $425 million. Through March 2, 2023, we had repurchased an aggregate of $6.89 billion under the authorization. Amounts repurchased are included in treasury stock. Dividends : We declared and paid dividends of $126 million ($0.115 per share) in each of the second and first quarters of 2023. Accumulated Other Comprehensive Income (Loss) : Changes in accumulated other comprehensive income (loss) by component for the six months ended March 2, 2023 were as follows: Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of September 1, 2022 $ (538) $ (47) $ 25 $ — $ (560) Other comprehensive income (loss) before reclassifications 132 — — (2) 130 Amount reclassified out of accumulated other comprehensive income (loss) 122 1 1 — 124 Tax effects (54) (13) — — (67) Other comprehensive income (loss) 200 (12) 1 (2) 187 As of March 2, 2023 $ (338) $ (59) $ 26 $ (2) $ (373)

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Mar. 02, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The estimated fair values and carrying values of our outstanding debt instruments were as follows: March 2, 2023 September 1, 2022 As of Fair Carrying Fair Carrying Notes $ 10,577 $ 11,203 $ 5,472 $ 6,020 The fair values of our debt instruments were estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

Derivative Instruments

Derivative Instruments	6 Months Ended
	Mar. 02, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of March 2, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 4,116 $ 60 $ (116) Cash flow commodity hedges 102 2 (6) Fair value interest rate hedges 900 — (115) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,454 4 (8) $ 66 $ (245) As of September 1, 2022 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 5,427 $ — $ (330) Cash flow commodity hedges 97 1 (6) Fair value interest rate hedges 900 — (91) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,821 7 (13) $ 8 $ (440) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities. Derivative Instruments with Hedge Accounting Designation Cash Flow Hedges : We utilize forward and swap contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs. Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). We recognized gains from cash flow hedges of $75 million and $128 million for the second quarter and first six months of 2023, respectively, and losses of $70 million and $170 million for the second quarter and first six months of 2022, respectively, in accumulated other comprehensive income (loss). We reclassified losses of $54 million and $122 million for the second quarter and first six months of 2023, respectively, from accumulated other comprehensive income (loss) to earnings, primarily to cost of goods sold. The reclassifications for the second quarter and first six months of 2022 were not significant. As of March 2, 2023, we expect to reclassify $220 million of pre-tax losses related to cash flow hedges from accumulated other comprehensive income (loss) into earnings in the next 12 months. Fair Value Hedges : We utilize fixed-to-floating interest rate swaps designated as fair value hedges to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Interest rate swaps are measured at fair value based on market-based observable inputs including interest rates and credit-risk spreads (Level 2). The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or been extinguished. The effects of fair value hedges on our consolidated statements of operations, recognized in interest expense, were not significant for the periods presented. Currency Derivatives :

Equity Plans

Equity Plans	6 Months Ended
	Mar. 02, 2023
Share-Based Payment Arrangement [Abstract]
Equity Plans	Equity Plans As of March 2, 2023, 50 million shares of our common stock were available for future awards under our equity plans, including 16 million shares approved for issuance under our employee stock purchase plan (“ESPP”). Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”) Restricted Stock Awards activity is summarized as follows: Six months ended March 2, March 3, Restricted stock award shares granted 14 10 Weighted-average grant-date fair value per share $ 54.00 $ 71.31 Employee Stock Purchase Plan (“ESPP”) For each six-month ESPP offering period that ended in the second quarter of 2023 and 2022, employees purchased 3 million and 2 million shares, respectively, at a per share price of $52.45 and $65.94, respectively. Stock-based Compensation Expense Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $92 million and $48 million was capitalized and remained in inventory as of March 2, 2023 and September 1, 2022, respectively. Quarter ended Six months ended March 2, March 3, March 2, March 3, Stock-based compensation expense by caption Research and development $ 59 $ 45 $ 112 $ 83 Cost of goods sold 40 45 76 88 Selling, general, and administrative 36 30 73 65 Restructure (2) — (2) (5) $ 133 $ 120 $ 259 $ 231 Stock-based compensation expense by type of award Restricted stock awards $ 116 $ 104 $ 225 $ 200 ESPP 17 16 34 30 Stock options — — — 1 $ 133 $ 120 $ 259 $ 231 As of March 2, 2023, $1.43 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the second quarter of 2027, resulting in a weighted-average period of 1.4 years.

Revenue

Revenue	6 Months Ended
	Mar. 02, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Substantially all contracts with our customers are short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year. As of March 2, 2023, our future performance obligations beyond one year were not significant. As of March 2, 2023 and September 1, 2022, other current liabilities included $605 million and $1.26 billion, respectively, for estimates of consideration payable to customers including estimates for pricing adjustments and returns. In the second quarter of 2023, we received $120 million in cash as settlement of an insurance claim involving an operational disruption in 2017, of which $114 million was for business interruption and recognized in revenue. Revenue by Technology Quarter ended Six months ended March 2, March 3, March 2, March 3, DRAM $ 2,722 $ 5,719 $ 5,551 $ 11,306 NAND 885 1,957 1,988 3,835 Other (primarily NOR) 86 110 239 332 $ 3,693 $ 7,786 $ 7,778 $ 15,473 See “Segment and Other Information” for disclosure of disaggregated revenue by market segment.

Restructure and Asset Impairmen

Restructure and Asset Impairments	6 Months Ended
	Mar. 02, 2023
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Restructure and Asset Impairments Quarter ended Six months ended March 2, March 3, March 2, March 3, Employee severance $ 80 $ — $ 93 $ — Asset impairments and other asset-related costs 8 5 8 59 Other (2) — (2) (16) Restructure and asset impairments $ 86 $ 5 $ 99 $ 43 In 2023, we initiated a restructure plan in response to challenging industry conditions (the “2023 Restructure Plan”). Under the 2023 Restructure Plan, we expect our headcount reduction to approach 15% by the end of calendar 2023, through a combination of voluntary attrition and personnel reductions. In connection with the plan, we incurred restructure charges of $86 million and $99 million in the second quarter and first six months of 2023 respectively, primarily related to employee severance costs. As of March 2, 2023, total costs expected to be incurred under the 2023 Restructure Plan were approximately $160 million. We expect the plan to be substantially completed by the end of the third quarter of 2023. Changes in our restructure liability (included in accounts payable and accrued expenses) for the six months ended March 2, 2023 were as follows: Employee Severance Restructure liability as of September 1, 2022 $ — Costs incurred and charged to expense 93 Costs paid or otherwise settled (37) Restructure liability as of March 2, 2023 $ 56

Other Non-Operating Income (Exp

Other Non-Operating Income (Expense), Net	6 Months Ended
	Mar. 02, 2023
Other Nonoperating Income (Expense) [Abstract]
Other Non-Operating Income (Expense), Net	Other Non-Operating Income (Expense), Net Quarter ended Six months ended March 2, March 3, March 2, March 3, Gain (loss) on investments $ (2) $ 3 $ (11) $ 13 Gain (loss) on debt repurchases — — — (83) Other 4 3 9 1 $ 2 $ 6 $ (2) $ (69)

Income Taxes

Income Taxes	6 Months Ended
	Mar. 02, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax (provision) benefit consisted of the following: Quarter ended Six months ended March 2, March 3, March 2, March 3, Income (loss) before taxes $ (2,271) $ 2,509 $ (2,447) $ 5,030 Income tax (provision) benefit (54) (255) (62) (474) Effective tax rate (2.4) % 10.2 % (2.5) % 9.4 % The changes in our effective tax rate for the second quarter and first six months of 2023 as compared to the corresponding periods of 2022 were primarily due to pre-tax losses incurred in the first six months of 2023. Despite a consolidated pre-tax loss on a worldwide basis, we have taxes payable in certain geographies due to minimum taxable income reportable in those geographies.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Mar. 02, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Quarter ended Six months ended March 2, March 3, March 2, March 3, Net income (loss) – Basic and Diluted $ (2,312) $ 2,263 $ (2,507) $ 4,569 Weighted-average common shares outstanding – Basic 1,091 1,119 1,091 1,119 Dilutive effect of equity plans — 11 — 11 Weighted-average common shares outstanding – Diluted 1,091 1,130 1,091 1,130 Earnings (loss) per share Basic $ (2.12) $ 2.02 $ (2.30) $ 4.08 Diluted (2.12) 2.00 (2.30) 4.04 Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were 33 million and 34 million for the second quarter and first six months of 2023, respectively, and were 2 million for the second quarter and first six months of 2022.

Segment and Other Information

Segment and Other Information	6 Months Ended
	Mar. 02, 2023
Segment Reporting [Abstract]
Segment and Other Information	Segment and Other Information Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments: Compute and Networking Business Unit (“CNBU”) : Includes memory products sold into client, cloud server, enterprise, graphics, and networking markets. Mobile Business Unit (“MBU”) : Includes memory and storage products sold into smartphone and other mobile-device markets. Embedded Business Unit (“EBU”) : Includes memory and storage products sold into automotive, industrial, and consumer markets. Storage Business Unit (“SBU”) : Includes SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. Quarter ended Six months ended March 2, March 3, March 2, March 3, Revenue CNBU $ 1,375 $ 3,461 $ 3,121 $ 6,867 MBU 945 1,875 1,600 3,782 EBU 865 1,277 1,865 2,497 SBU 507 1,171 1,187 2,321 All Other 1 2 5 6 $ 3,693 $ 7,786 $ 7,778 $ 15,473 Operating income (loss) CNBU $ (35) $ 1,562 $ 155 $ 3,086 MBU (344) 588 (539) 1,212 EBU 88 421 282 843 SBU (357) 178 (614) 330 All Other 1 1 4 4 (647) 2,750 (712) 5,475 Unallocated Provision to write-down inventories to net realizable value (1,430) — (1,430) — Stock-based compensation (136) (119) (262) (235) Restructure and asset impairments (86) (5) (99) (43) Other (4) (80) (9) (20) (1,656) (204) (1,800) (298) Operating income (loss) $ (2,303) $ 2,546 $ (2,512) $ 5,177

Certain Concentrations

Certain Concentrations	6 Months Ended
	Mar. 02, 2023
Risks and Uncertainties [Abstract]
Certain Concentrations	Certain Concentrations Revenue for key market segments as an approximate percent of total revenue is presented in the table below: Six months ended March 2, March 3, Automotive, industrial, and consumer 25 % 15 % Enterprise and cloud server 20 % 20 % Client and graphics 20 % 20 % Mobile 20 % 25 % SSDs and other storage 15 % 15 %

Subsequent Events

Subsequent Events	6 Months Ended
	Mar. 02, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On March 10, 2023, we reached an agreement in principle to settle an insurance claim involving a power disruption in 2022, under which we expect to receive approximately $110 million in cash, of which approximately $70 million is for business interruption and will be recognized in revenue. On March 27, 2023, we entered into amendments to the Term Loan Agreement and the agreements governing the Revolving Credit Facility and the 2024 Term Loan A to revise the leverage ratio covenant in each such agreement, as further described in “Item 1. Financial Statements – Notes to Consolidated Financial Statements – Debt.” On March 28, 2023, our Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on April 25, 2023, to shareholders of record as of the close of business on April 10, 2023.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Mar. 02, 2023
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended September 1, 2022.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2023 and 2022 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated.

Segment Reporting (Policies)

Segment Reporting (Policies)	6 Months Ended
	Mar. 02, 2023
Segment Reporting [Abstract]
Segment Reporting Policy	Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

Cash and Investments (Tables)

Cash and Investments (Tables)	6 Months Ended
	Mar. 02, 2023
Investments and Cash [Abstract]
Cash and Investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: March 2, 2023 September 1, 2022 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,222 $ — $ — $ 6,222 $ 6,055 $ — $ — $ 6,055 Level 1 (2) Money market funds 1,893 — — 1,893 1,196 — — 1,196 Level 2 (3) Certificates of deposit 1,654 61 — 1,715 976 50 — 1,026 Corporate bonds 10 761 700 1,471 — 759 995 1,754 Asset-backed securities — 13 475 488 — 20 608 628 Government securities 10 101 37 148 2 155 44 201 Commercial paper 9 84 — 93 33 85 — 118 9,798 $ 1,020 $ 1,212 $ 12,030 8,262 $ 1,069 $ 1,647 $ 10,978 Restricted cash (4) 89 77 Cash, cash equivalents, and restricted cash $ 9,887 $ 8,339 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of March 2, 2023 or September 1, 2022.
Cash and equivalents and the fair values of available-for-sale investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: March 2, 2023 September 1, 2022 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,222 $ — $ — $ 6,222 $ 6,055 $ — $ — $ 6,055 Level 1 (2) Money market funds 1,893 — — 1,893 1,196 — — 1,196 Level 2 (3) Certificates of deposit 1,654 61 — 1,715 976 50 — 1,026 Corporate bonds 10 761 700 1,471 — 759 995 1,754 Asset-backed securities — 13 475 488 — 20 608 628 Government securities 10 101 37 148 2 155 44 201 Commercial paper 9 84 — 93 33 85 — 118 9,798 $ 1,020 $ 1,212 $ 12,030 8,262 $ 1,069 $ 1,647 $ 10,978 Restricted cash (4) 89 77 Cash, cash equivalents, and restricted cash $ 9,887 $ 8,339 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of March 2, 2023 or September 1, 2022.

Receivables (Tables)

Receivables (Tables)	6 Months Ended
	Mar. 02, 2023
Receivables [Abstract]
Schedule of Receivables	As of March 2, September 1, Trade receivables $ 1,891 $ 4,765 Income and other taxes 215 251 Other 172 114 $ 2,278 $ 5,130

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Mar. 02, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories	As of March 2, September 1, Finished goods $ 1,631 $ 1,028 Work in process 5,653 4,830 Raw materials and supplies 845 805 $ 8,129 $ 6,663

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	6 Months Ended
	Mar. 02, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant, and Equipment	As of March 2, September 1, Land $ 279 $ 280 Buildings 17,401 16,676 Equipment (1) 64,279 61,354 Construction in progress (2) 2,093 1,897 Software 1,247 1,124 85,299 81,331 Accumulated depreciation (46,214) (42,782) $ 39,085 $ 38,549 (1) Includes costs related to equipment not placed into service of $3.43 billion as of March 2, 2023 and $3.35 billion as of September 1, 2022. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Mar. 02, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	March 2, 2023 September 1, 2022 As of Gross Accumulated Net Carrying Gross Accumulated Net Carrying Product and process technology $ 740 $ (330) $ 410 $ 742 $ (321) $ 421

Leases (Tables)

Leases (Tables)	6 Months Ended
	Mar. 02, 2023
Leases [Abstract]
Schedule of Components of Lease Expense	Quarter ended Six months ended March 2, March 3, March 2, March 3, Finance lease cost Amortization of right-of-use assets $ 25 $ 27 $ 49 $ 52 Interest on lease liabilities 6 6 12 12 Operating lease cost (1) 31 30 67 59 $ 62 $ 63 $ 128 $ 123
Schedule of Other Lease Information	Supplemental cash flow information related to leases was as follows: Six months ended March 2, March 3, Cash flows used for operating activities Finance leases $ 11 $ 11 Operating leases 60 56 Cash flows used for financing activities – Finance leases 53 52 Noncash acquisitions of right-of-use assets Finance leases 225 304 Operating leases 35 68 Supplemental balance sheet information related to leases was as follows: As of March 2, September 1, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,084 $ 904 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 60 Weighted-average remaining lease term (in years) Finance leases 10 12 Operating leases 11 12 Weighted-average discount rate Finance leases 2.40 % 2.65 % Operating leases 3.06 % 2.90 %
Schedule of Finance Lease Maturities	For the year ending Finance Leases Operating Leases Remainder of 2023 $ 78 $ 13 2024 152 73 2025 138 73 2026 129 72 2027 126 72 2028 and thereafter 619 524 Less imputed interest (171) (156) $ 1,071 $ 671
Schedule of Operating Lease Maturities	For the year ending Finance Leases Operating Leases Remainder of 2023 $ 78 $ 13 2024 152 73 2025 138 73 2026 129 72 2027 126 72 2028 and thereafter 619 524 Less imputed interest (171) (156) $ 1,071 $ 671

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	6 Months Ended
	Mar. 02, 2023
Payables and Accruals [Abstract]
Schedule of Accounts Payable And Accrued Expenses	As of March 2, September 1, Accounts payable $ 1,689 $ 2,142 Property, plant, and equipment 1,712 2,170 Salaries, wages, and benefits 320 877 Income and other taxes 241 420 Other 348 481 $ 4,310 $ 6,090

Debt (Tables)

Debt (Tables)	6 Months Ended
	Mar. 02, 2023
Debt Disclosure [Abstract]
Schedule of Debt	March 2, 2023 September 1, 2022 Net Carrying Amount Net Carrying Amount As of Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total 2024 Term Loan A 5.340 % 5.38 % $ — $ 1,187 $ 1,187 $ — $ 1,187 $ 1,187 2025 Term Loan A 5.968 % 6.10 % — 1,050 1,050 — — — 2026 Term Loan A 6.093 % 6.23 % 49 946 995 — — — 2027 Term Loan A 6.218 % 6.36 % 57 1,092 1,149 — — — 2026 Notes 4.975 % 5.07 % — 499 499 — 498 498 2027 Notes (1) 4.185 % 4.27 % — 783 783 — 806 806 2029 A Notes 5.327 % 5.40 % — 697 697 — 697 697 2029 B Notes 6.750 % 6.54 % — 1,264 1,264 — — — 2030 Notes 4.663 % 4.73 % — 846 846 — 846 846 2032 Green Bonds 2.703 % 2.77 % — 995 995 — 994 994 2033 Notes 5.875 % 5.96 % — 745 745 — — — 2041 Notes 3.366 % 3.41 % — 497 497 — 496 496 2051 Notes 3.477 % 3.52 % — 496 496 — 496 496 Finance lease obligations N/A 2.40 % 131 940 1,071 103 783 886 $ 237 $ 12,037 $ 12,274 $ 103 $ 6,803 $ 6,906
Schedule of Debt Activity	Increase in Principal Increase in Carrying Value Increase in Cash 2025 Term Loan A $ 1,052 $ 1,050 $ 1,050 2026 Term Loan A 996 994 994 2027 Term Loan A 1,152 1,149 1,149 2029 B Notes 1,250 1,264 1,264 2033 Notes 750 745 745 $ 5,200 $ 5,202 $ 5,202
Schedule of Maturities of Notes Payable	As of March 2, 2023, maturities of notes payable by fiscal year were as follows: Remainder of 2023 $ 54 2024 107 2025 1,295 2026 1,659 2027 1,780 2028 and thereafter 6,443 Unamortized issuance costs, discounts, and premium, net (21) Hedge accounting fair value adjustment (114) $ 11,203

Equity (Tables)

Equity (Tables)	6 Months Ended
	Mar. 02, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of September 1, 2022 $ (538) $ (47) $ 25 $ — $ (560) Other comprehensive income (loss) before reclassifications 132 — — (2) 130 Amount reclassified out of accumulated other comprehensive income (loss) 122 1 1 — 124 Tax effects (54) (13) — — (67) Other comprehensive income (loss) 200 (12) 1 (2) 187 As of March 2, 2023 $ (338) $ (59) $ 26 $ (2) $ (373)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Mar. 02, 2023
Fair Value Disclosures [Abstract]
Estimated Fair Value and Carrying Value of Debt Instruments	March 2, 2023 September 1, 2022 As of Fair Carrying Fair Carrying Notes $ 10,577 $ 11,203 $ 5,472 $ 6,020

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Mar. 02, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of March 2, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 4,116 $ 60 $ (116) Cash flow commodity hedges 102 2 (6) Fair value interest rate hedges 900 — (115) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,454 4 (8) $ 66 $ (245) As of September 1, 2022 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 5,427 $ — $ (330) Cash flow commodity hedges 97 1 (6) Fair value interest rate hedges 900 — (91) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,821 7 (13) $ 8 $ (440) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities.

Equity Plans (Tables)

Equity Plans (Tables)	6 Months Ended
	Mar. 02, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Stock Awards Activity	Six months ended March 2, March 3, Restricted stock award shares granted 14 10 Weighted-average grant-date fair value per share $ 54.00 $ 71.31
Stock-based Compensation Expense	Quarter ended Six months ended March 2, March 3, March 2, March 3, Stock-based compensation expense by caption Research and development $ 59 $ 45 $ 112 $ 83 Cost of goods sold 40 45 76 88 Selling, general, and administrative 36 30 73 65 Restructure (2) — (2) (5) $ 133 $ 120 $ 259 $ 231 Stock-based compensation expense by type of award Restricted stock awards $ 116 $ 104 $ 225 $ 200 ESPP 17 16 34 30 Stock options — — — 1 $ 133 $ 120 $ 259 $ 231

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Mar. 02, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Quarter ended Six months ended March 2, March 3, March 2, March 3, DRAM $ 2,722 $ 5,719 $ 5,551 $ 11,306 NAND 885 1,957 1,988 3,835 Other (primarily NOR) 86 110 239 332 $ 3,693 $ 7,786 $ 7,778 $ 15,473

Restructure and Asset Impairm_2

Restructure and Asset Impairments (Tables)	6 Months Ended
	Mar. 02, 2023
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Quarter ended Six months ended March 2, March 3, March 2, March 3, Employee severance $ 80 $ — $ 93 $ — Asset impairments and other asset-related costs 8 5 8 59 Other (2) — (2) (16) Restructure and asset impairments $ 86 $ 5 $ 99 $ 43
Schedule of Restructuring Reserve by Type of Cost	Employee Severance Restructure liability as of September 1, 2022 $ — Costs incurred and charged to expense 93 Costs paid or otherwise settled (37) Restructure liability as of March 2, 2023 $ 56

Other Non-Operating Income (E_2

Other Non-Operating Income (Expense), Net (Tables)	6 Months Ended
	Mar. 02, 2023
Other Nonoperating Income (Expense) [Abstract]
Schedule of Other Nonoperating Income (Expense), Net	Quarter ended Six months ended March 2, March 3, March 2, March 3, Gain (loss) on investments $ (2) $ 3 $ (11) $ 13 Gain (loss) on debt repurchases — — — (83) Other 4 3 9 1 $ 2 $ 6 $ (2) $ (69)

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Mar. 02, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Tax (Provision) Benefit	Quarter ended Six months ended March 2, March 3, March 2, March 3, Income (loss) before taxes $ (2,271) $ 2,509 $ (2,447) $ 5,030 Income tax (provision) benefit (54) (255) (62) (474) Effective tax rate (2.4) % 10.2 % (2.5) % 9.4 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Mar. 02, 2023
Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	Quarter ended Six months ended March 2, March 3, March 2, March 3, Net income (loss) – Basic and Diluted $ (2,312) $ 2,263 $ (2,507) $ 4,569 Weighted-average common shares outstanding – Basic 1,091 1,119 1,091 1,119 Dilutive effect of equity plans — 11 — 11 Weighted-average common shares outstanding – Diluted 1,091 1,130 1,091 1,130 Earnings (loss) per share Basic $ (2.12) $ 2.02 $ (2.30) $ 4.08 Diluted (2.12) 2.00 (2.30) 4.04

Segment and Other Information (

Segment and Other Information (Tables)	6 Months Ended
	Mar. 02, 2023
Segment Reporting [Abstract]
Schedule of Results by Segment	Quarter ended Six months ended March 2, March 3, March 2, March 3, Revenue CNBU $ 1,375 $ 3,461 $ 3,121 $ 6,867 MBU 945 1,875 1,600 3,782 EBU 865 1,277 1,865 2,497 SBU 507 1,171 1,187 2,321 All Other 1 2 5 6 $ 3,693 $ 7,786 $ 7,778 $ 15,473 Operating income (loss) CNBU $ (35) $ 1,562 $ 155 $ 3,086 MBU (344) 588 (539) 1,212 EBU 88 421 282 843 SBU (357) 178 (614) 330 All Other 1 1 4 4 (647) 2,750 (712) 5,475 Unallocated Provision to write-down inventories to net realizable value (1,430) — (1,430) — Stock-based compensation (136) (119) (262) (235) Restructure and asset impairments (86) (5) (99) (43) Other (4) (80) (9) (20) (1,656) (204) (1,800) (298) Operating income (loss) $ (2,303) $ 2,546 $ (2,512) $ 5,177

Certain Concentrations (Tables)

Certain Concentrations (Tables)	6 Months Ended
	Mar. 02, 2023
Risks and Uncertainties [Abstract]
Schedule of Market Concentration Risk	Revenue for key market segments as an approximate percent of total revenue is presented in the table below: Six months ended March 2, March 3, Automotive, industrial, and consumer 25 % 15 % Enterprise and cloud server 20 % 20 % Client and graphics 20 % 20 % Mobile 20 % 25 % SSDs and other storage 15 % 15 %

Cash and Investments (Details)

Cash and Investments (Details) - USD ($) $ in Millions		Mar. 02, 2023	Sep. 01, 2022	Mar. 03, 2022	Sep. 02, 2021
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 9,798	$ 8,262
Short-term Investments		1,020	1,069
Long-term Marketable Investments	[1]	1,212	1,647
Total Fair Value		12,030	10,978
Restricted cash	[2]	89	77
Cash, cash equivalents, and restricted cash		$ 9,887	8,339	$ 9,224	$ 7,829
Minimum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		1 year
Maximum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		4 years
Cash
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 6,222	6,055
Short-term Investments		0	0
Long-term Marketable Investments		0	0
Total Fair Value		6,222	6,055
Money market funds | Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[3]	1,893	1,196
Short-term Investments	[3]	0	0
Long-term Marketable Investments	[1],[3]	0	0
Total Fair Value	[3]	1,893	1,196
Certificates of deposit | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	1,654	976
Short-term Investments	[4]	61	50
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	1,715	1,026
Corporate bonds | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	10	0
Short-term Investments	[4]	761	759
Long-term Marketable Investments	[1],[4]	700	995
Total Fair Value	[4]	1,471	1,754
Asset-backed securities | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	0
Short-term Investments	[4]	13	20
Long-term Marketable Investments	[1],[4]	475	608
Total Fair Value	[4]	488	628
Government securities | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	10	2
Short-term Investments	[4]	101	155
Long-term Marketable Investments	[1],[4]	37	44
Total Fair Value	[4]	148	201
Commercial paper | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	9	33
Short-term Investments	[4]	84	85
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	$ 93	$ 118
[1] The maturities of long-term marketable securities primarily range from one four years.

Cash and Investments - Non-mark

Cash and Investments - Non-marketable Equity Investments (Details) - USD ($) $ in Millions	Mar. 02, 2023	Sep. 01, 2022
Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]
Equity Securities without Readily Determinable Fair Value, Amount	$ 218	$ 222

Receivables (Details)

Receivables (Details) - USD ($) $ in Millions	Mar. 02, 2023	Sep. 01, 2022
Receivables [Abstract]
Trade receivables	$ 1,891	$ 4,765
Income and other taxes	215	251
Other	172	114
Receivables	$ 2,278	$ 5,130

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Mar. 02, 2023	Mar. 02, 2023	Mar. 03, 2022	Sep. 01, 2022
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 1,631	$ 1,631		$ 1,028
Work in process	5,653	5,653		4,830
Raw materials and supplies	845	845		805
Inventories	8,129	8,129		$ 6,663
Production Related Impairments or Charges [Abstract]
Provision to write-down inventories to net realizable value	$ 1,430	$ 1,430	$ 0

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($) $ in Millions		Mar. 02, 2023	Sep. 01, 2022
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 85,299	$ 81,331
Accumulated depreciation		(46,214)	(42,782)
Property, plant, and equipment, net		39,085	38,549
Land
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		279	280
Buildings
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		17,401	16,676
Equipment(1)
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[1]	64,279	61,354
Equipment not placed into service
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		3,430	3,350
Construction in progress(2)
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[2]	2,093	1,897
Software
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 1,247	$ 1,124
[1]Includes costs related to equipment not placed into service of $3.43 billion as of March 2, 2023 and $3.35 billion as of September 1, 2022.[2]Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Sep. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Product and process technology, Gross	$ 740		$ 742
Accumulated amortization	(330)		(321)
Product and process technology, net	410		$ 421
Amortizing assets [Line Items]
Increase in product and process technology	51	$ 105
Amortization [Abstract]
Amortization of Intangible Assets	45	$ 40
Annual amortization expense for intangible assets [Abstract]
Remainder of 2023	42
2024	73
2025	52
2026	46
2027	$ 40
Weighted Average
Amortizing assets [Line Items]
Useful lives of assets placed into service	10 years	7 years

Leases - Cost and Cash Flows (D

Leases - Cost and Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022	Sep. 01, 2022
Components of Lease Expense
Amortization of right-of-use assets		$ 25	$ 27	$ 49	$ 52
Interest on lease liabilities		6	6	12	12
Operating lease cost(1)	[1]	31	30	67	59
Total lease cost		$ 62	$ 63	128	123
Cash flows used for operating activities
Finance leases				11	11
Operating leases				60	56
Cash flows used for financing activities
Cash flows used for financing activities – Finance leases				53	52
Finance leases, noncash acquisitions of right-of-use assets				225	304
Operating leases, noncash acquisitions of right-of-use assets				$ 35	$ 68
Lessee, Finance Lease Description
Finance Lease Right-of-Use Asset, Balance Sheet Location		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance lease right-of-use assets (included in property, plant, and equipment)		$ 1,084		$ 1,084		$ 904
Finance leases, Weighted-average remaining lease term (in years)		10 years		10 years		12 years
Finance leases, Weighted-average discount rate		2.40%		2.40%		2.65%
Lessee, Operating Lease Description
Operating Lease Liability, Balance Sheet Location		Accounts payable and accrued expenses		Accounts payable and accrued expenses		Accounts payable and accrued expenses
Current operating lease liabilities (included in accounts payable and accrued expenses)		$ 60		$ 60		$ 60
Operating leases, Weighted-average remaining lease term (in years)		11 years		11 years		12 years
Operating leases, Weighted-average discount rate		3.06%		3.06%		2.90%
[1]Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented.

Leases - Maturities (Details)

Leases - Maturities (Details) - USD ($) $ in Millions	Mar. 02, 2023	Sep. 01, 2022
Finance Lease Maturities
Remainder of 2023	$ 78
2024	152
2025	138
2026	129
2027	126
2028 and thereafter	619
Less imputed interest	(171)
Finance Lease Liability	1,071	$ 886
Operating Lease Maturities
Remainder of 2023	13
2024	73
2025	73
2026	72
2027	72
2028 and thereafter	524
Less imputed interest	(156)
Operating Lease Liability	$ 671

Leases - Not Yet Commenced (Det

Leases - Not Yet Commenced (Details) $ in Millions	Mar. 02, 2023 USD ($)
Finance Lease Not yet Commenced
Payment obligations	$ 195
Weighted Average
Finance Lease Not yet Commenced
Lease term	11 years

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Mar. 02, 2023	Sep. 01, 2022
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 1,689	$ 2,142
Property, plant, and equipment	1,712	2,170
Salaries, wages, and benefits	320	877
Income and other taxes	241	420
Other	348	481
Total accounts payable and accrued expenses	$ 4,310	$ 6,090

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($)				6 Months Ended
		Nov. 03, 2022	Oct. 31, 2022	Mar. 02, 2023	Mar. 27, 2023	Feb. 09, 2023	Jan. 05, 2023	Sep. 01, 2022
Long-term Debt by Current and Noncurrent
Total Long-term Debt				$ 11,203,000,000
Finance Lease Effective Rate (in ten thousandths)				2.40%				2.65%
Current Finance Lease Obligations				$ 131,000,000				$ 103,000,000
Long-Term Finance Lease Obligations				940,000,000				783,000,000
Total Finance Lease Obligations				1,071,000,000				886,000,000
Long-term Debt and Lease Obligation
Current debt (including finance lease obligation)				237,000,000				103,000,000
Long-term debt (including finance lease obligation)				12,037,000,000				6,803,000,000
Total Net Carrying Amount of Debt (including finance lease obligation)				$ 12,274,000,000				$ 6,906,000,000
Current finance lease liability, statement of financial position				Current debt (including finance lease obligation)				Current debt (including finance lease obligation)
Noncurrent finance lease liability, statement of financial position				Long-term debt (including finance lease obligation)				Long-term debt (including finance lease obligation)
Debt Activity
Increase in Principal				$ 5,200,000,000
Increase in Carrying Value				5,202,000,000
Increase in Cash				5,202,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Debt Issuance Costs		$ 6,000,000
Maturities of Notes Payable
Remainder of 2023				54,000,000
2024				107,000,000
2025				1,295,000,000
2026				1,659,000,000
2027				1,780,000,000
2028 and thereafter				6,443,000,000
Unamortized issuance costs, discounts, and premium, net				(21,000,000)
Hedge accounting fair value adjustment				(114,000,000)
Total Long-term Debt				11,203,000,000
Interest rate swap | Fair value hedges | Designated hedging instruments
Long-term Debt and Lease Obligation
Notional or Contractual Amount				$ 900,000,000				$ 900,000,000
SOFR | Interest rate swap | Fair value hedges | Designated hedging instruments
Long-term Debt and Lease Obligation
Spread on 2027 Variable Interest Rate				3.33%
Term Loan
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued		$ 2,600,000,000					$ 600,000,000
Debt Covenant, Ratio Of Total Debt To Adjusted EBITDA		325%
Term Loan | Subsequent Event
2024 Term Loans, 2029 B Notes, & 2033 Notes
Debt Covenant, Ratio Of Net Debt To Adjusted EBITDA					325%
Debt Covenant, Minimum Liquidity					$ 5,000,000,000
Debt Covenant, Ratio of Total Debt To Adjusted EBITDA, Temporary Increase					375%
Term Loan | SOFR | Minimum
Revolving Credit Facility
Margin on variable rate financing		1%
Term Loan | SOFR | Maximum
Revolving Credit Facility
Margin on variable rate financing		2%
Term Loan | 2024 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				5.34%
Effective Rate (in ten thousandths)				5.38%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				1,187,000,000				1,187,000,000
Total Long-term Debt				1,187,000,000				1,187,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 1,187,000,000				1,187,000,000
Term Loan | 2025 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				5.968%
Effective Rate (in ten thousandths)				6.10%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				1,050,000,000				0
Total Long-term Debt				1,050,000,000				0
Debt Activity
Increase in Principal				1,052,000,000
Increase in Carrying Value				1,050,000,000
Increase in Cash				1,050,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued		$ 927,000,000					125,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 1,050,000,000				0
Term Loan | 2026 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				6.093%
Effective Rate (in ten thousandths)				6.23%
Current Portion of Long-term Debt				$ 49,000,000				0
Noncurrent Long-Term Debt				946,000,000				0
Total Long-term Debt				995,000,000				0
Debt Activity
Increase in Principal				996,000,000
Increase in Carrying Value				994,000,000
Increase in Cash				994,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued		$ 746,000,000					250,000,000
Quarterly installment percentage		1.25%
Maturities of Notes Payable
Total Long-term Debt				$ 995,000,000				0
Term Loan | 2027 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				6.218%
Effective Rate (in ten thousandths)				6.36%
Current Portion of Long-term Debt				$ 57,000,000				0
Noncurrent Long-Term Debt				1,092,000,000				0
Total Long-term Debt				1,149,000,000				0
Debt Activity
Increase in Principal				1,152,000,000
Increase in Carrying Value				1,149,000,000
Increase in Cash				1,149,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued		$ 927,000,000					$ 225,000,000
Quarterly installment percentage		1.25%
Maturities of Notes Payable
Total Long-term Debt				$ 1,149,000,000				0
Corporate Bonds
2024 Term Loans, 2029 B Notes, & 2033 Notes
Debt Issuance Costs						$ 7,000,000
Corporate Bonds | 2026 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				4.975%
Effective Rate (in ten thousandths)				5.07%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				499,000,000				498,000,000
Total Long-term Debt				499,000,000				498,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 499,000,000				498,000,000
Corporate Bonds | 2027 Notes(1)
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)	[1]			4.185%
Effective Rate (in ten thousandths)	[1]			4.27%
Current Portion of Long-term Debt	[1]			$ 0				0
Noncurrent Long-Term Debt	[1]			783,000,000				806,000,000
Total Long-term Debt	[1]			783,000,000				806,000,000
Maturities of Notes Payable
Total Long-term Debt	[1]			$ 783,000,000				806,000,000
Corporate Bonds | 2029 A Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				5.327%
Effective Rate (in ten thousandths)				5.40%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				697,000,000				697,000,000
Total Long-term Debt				697,000,000				697,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 697,000,000				697,000,000
Corporate Bonds | 2029 B Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			6.75%	6.75%
Effective Rate (in ten thousandths)				6.54%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				1,264,000,000				0
Total Long-term Debt				1,264,000,000				0
Debt Activity
Increase in Principal				1,250,000,000
Increase in Carrying Value				1,264,000,000
Increase in Cash				1,264,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued			$ 750,000,000			500,000,000
Debt Issuance Costs			$ 6,000,000
Senior Unsecured Notes
Unamortized Debt Issuance Premium						$ 22,000,000
Redemption price percentage upon change in control			100%
Debt Instrument, Redemption Price Percentage, Change in Control Event			101%
Debt Covenant, Restricted Subsidiaries, Ownership Percentage by Parent (in hundredths)			80%
Maturities of Notes Payable
Total Long-term Debt				$ 1,264,000,000				0
Corporate Bonds | 2030 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				4.663%
Effective Rate (in ten thousandths)				4.73%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				846,000,000				846,000,000
Total Long-term Debt				846,000,000				846,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 846,000,000				846,000,000
Corporate Bonds | 2032 Green Bonds
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				2.703%
Effective Rate (in ten thousandths)				2.77%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				995,000,000				994,000,000
Total Long-term Debt				995,000,000				994,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 995,000,000				994,000,000
Corporate Bonds | 2033 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				5.875%		5.875%
Effective Rate (in ten thousandths)				5.96%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				745,000,000				0
Total Long-term Debt				745,000,000				0
Debt Activity
Increase in Principal				750,000,000
Increase in Carrying Value				745,000,000
Increase in Cash				745,000,000
2024 Term Loans, 2029 B Notes, & 2033 Notes
Principal amount of debt issued						$ 750,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 745,000,000				0
Corporate Bonds | 2041 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				3.366%
Effective Rate (in ten thousandths)				3.41%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				497,000,000				496,000,000
Total Long-term Debt				497,000,000				496,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 497,000,000				496,000,000
Corporate Bonds | 2051 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)				3.477%
Effective Rate (in ten thousandths)				3.52%
Current Portion of Long-term Debt				$ 0				0
Noncurrent Long-Term Debt				496,000,000				496,000,000
Total Long-term Debt				496,000,000				496,000,000
Maturities of Notes Payable
Total Long-term Debt				496,000,000				$ 496,000,000
Revolving Credit Facility | Subsequent Event
2024 Term Loans, 2029 B Notes, & 2033 Notes
Debt Covenant, Ratio Of Net Debt To Adjusted EBITDA					325%
Debt Covenant, Minimum Liquidity					$ 5,000,000,000
Debt Covenant, Ratio of Total Debt To Adjusted EBITDA, Temporary Increase					375%
Revolving Credit Facility | 2026 Revolving Credit Facility
Long-term Debt by Current and Noncurrent
Total Long-term Debt				0
Revolving Credit Facility
Available borrowing capacity				2,500,000,000
Maturities of Notes Payable
Total Long-term Debt				$ 0
Revolving Credit Facility | 2026 Revolving Credit Facility | LIBOR | Minimum
Revolving Credit Facility
Margin on variable rate financing				1%
Revolving Credit Facility | 2026 Revolving Credit Facility | LIBOR | Maximum
Revolving Credit Facility
Margin on variable rate financing				1.75%
[1]In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, as a result, the carrying values of our 2027 Notes reflect adjustments in fair value.

Commitments (Details)

Commitments (Details)	3 Months Ended
	Mar. 02, 2023
Power Purchase Agreement
Long-Term Purchase Commitment [Line Items]
Long-Term Purchase Commitment, Period	18 years

Contingencies (Details)

Contingencies (Details) - 6 months ended Mar. 02, 2023 ¥ in Millions, $ in Millions	CNY (¥) patent complaint	USD ($) patent complaint
Securities Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of pending complaints | complaint	1	1
Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 1 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Damages sought on alleged patent infringement | ¥	¥ 98
United Microelectronics Corporation vs Micron-Complaint 1 | Patent Matters | Withdrawn Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Damages sought on alleged patent infringement | ¥	¥ 90
United Microelectronics Corporation vs Micron-Complaint 2 | Patent Matters | Withdrawn Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Damages sought on alleged patent infringement | ¥	¥ 90
Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 2 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Damages sought on alleged patent infringement | ¥	¥ 98
Flash-Control, LLC vs Micron | Patent Matters
Loss Contingencies [Line Items]
Number of patents allegedly infringed	4	4
Number of patents found not infringed	2	2
Netlist Inc. vs Micron | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Netlist Inc vs Micron - Complaint 2 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	3	3
Netlist Inc. vs Micron - Complaint 3 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	2	2
Netlist Inc. vs Micron - Complaint 4 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	6	6
Netlist Inc. vs Micron - Complaint 5 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	2	2
Vervain LLC vs Micron | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	4	4
Bell Semiconductor, LLC District of Idaho | Patent Matters | Dismissed Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	6	6
Number of claims dismissed | complaint	4	4
Bell Semiconductor, LLC District of Delaware | Patent Matters | Dismissed Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	6	6
Bell Semiconductor LLC vs Micron and Others - ITC | Patent Matters | Dismissed Litigation
Loss Contingencies [Line Items]
Number of claims dismissed | complaint	1	1
Sonrai Memory, Ltd. vs Micron | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	2	2
Besang, Inc. vs Micron | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1	1
Qimonda AG Inotera Share Purchase Proceedings | Under Appeal
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation (in hundredths)	18%	18%
Loss contingency judgment, amount under appeal | $		$ 1
DRAM Purchasers Canada vs Micron | Antitrust Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of pending complaints | complaint	6	6

Equity - Common Stock Repurchas

Equity - Common Stock Repurchases and Dividends (Details) - USD ($)	3 Months Ended		6 Months Ended		54 Months Ended
	Mar. 02, 2023	Dec. 01, 2022	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023
Common Stock Repurchases
Payments for Repurchase of Common Stock			$ 425,000,000	$ 667,000,000
Dividends
Payments of Common Stock Dividends	$ 126,000,000	$ 126,000,000	252,000,000	$ 224,000,000
Payments of Common Stock Dividends (per share)	$ 0.115	$ 0.115
Repurchases Authorized by the BOD
Common Stock Repurchases
Common Stock Repurchase, Authorized Amount	$ 10,000,000,000		$ 10,000,000,000		$ 10,000,000,000
Treasury Shares Repurchased (in shares)	0	8,600,000
Payments for Repurchase of Common Stock		$ 425,000,000			$ 6,890,000,000

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 02, 2023	Dec. 01, 2022	Mar. 03, 2022	Dec. 02, 2021	Mar. 02, 2023	Mar. 03, 2022
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)		$ (560)			$ (560)
Other comprehensive income (loss) before reclassifications					130
Amount reclassified out of accumulated other comprehensive income (loss)					124
Tax effects					(67)
Other comprehensive income (loss)	$ 100	87	$ (47)	$ (93)	187	$ (140)
Accumulated other comprehensive income (loss)	(373)				(373)
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)		(538)			(538)
Other comprehensive income (loss) before reclassifications					132
Amount reclassified out of accumulated other comprehensive income (loss)					122
Tax effects					(54)
Other comprehensive income (loss)					200
Accumulated other comprehensive income (loss)	(338)				(338)
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)		(47)			(47)
Other comprehensive income (loss) before reclassifications					0
Amount reclassified out of accumulated other comprehensive income (loss)					1
Tax effects					(13)
Other comprehensive income (loss)					(12)
Accumulated other comprehensive income (loss)	(59)				(59)
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)		25			25
Other comprehensive income (loss) before reclassifications					0
Amount reclassified out of accumulated other comprehensive income (loss)					1
Tax effects					0
Other comprehensive income (loss)					1
Accumulated other comprehensive income (loss)	26				26
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)		$ 0			0
Other comprehensive income (loss) before reclassifications					(2)
Amount reclassified out of accumulated other comprehensive income (loss)					0
Tax effects					0
Other comprehensive income (loss)					(2)
Accumulated other comprehensive income (loss)	$ (2)				$ (2)

Fair Value Measurements - Fair

Fair Value Measurements - Fair and Carrying Value of Debt (Details) - USD ($) $ in Millions	Mar. 02, 2023	Sep. 01, 2022
Fair Value
Fair Value of Notes Payable
Notes (level 2)	$ 10,577	$ 5,472
Carrying Value
Fair Value of Notes Payable
Notes (level 2)	$ 11,203	$ 6,020

Derivative Instruments - Notion

Derivative Instruments - Notional Amounts and Fair Values (Details) - USD ($) $ in Millions		6 Months Ended
		Mar. 02, 2023	Sep. 01, 2022
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	$ 66	$ 8
Fair Value of Liabilities	[2]	$ (245)	(440)
Designated hedging instruments | Cash flow hedges
Fair Value of Derivative Assets and Liabilities
General maturity of cash flow hedges (in years)		2 years
Designated hedging instruments | Cash flow hedges | Currency hedges
Notional Disclosures
Notional or Contractual Amount		$ 4,116	5,427
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	60	0
Fair Value of Liabilities	[2]	(116)	(330)
Designated hedging instruments | Cash flow hedges | Commodity hedges
Notional Disclosures
Notional or Contractual Amount		102	97
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	2	1
Fair Value of Liabilities	[2]	(6)	(6)
Designated hedging instruments | Fair value hedges | Interest rate swap
Notional Disclosures
Notional or Contractual Amount		900	900
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	0	0
Fair Value of Liabilities	[2]	(115)	(91)
Not designated hedging instruments | Currency hedges
Notional Disclosures
Notional or Contractual Amount		1,454	2,821
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	4	7
Fair Value of Liabilities	[2]	$ (8)	$ (13)
General maturity of currency forward contracts (in months)		3 months
[1]Included in receivables and other noncurrent assets.[2]Included in accounts payable and accrued expenses and other noncurrent liabilities.

Derivative Instruments - Gain (

Derivative Instruments - Gain (Loss) on Derivatives (Details) - Designated hedging instruments - Cash flow hedges - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) recognized in other comprehensive income from cash flow hedges	$ 75	$ (70)	$ 128	$ (170)
Reclassifications form other comprehensive income (loss) to earnings	$ (54)		(122)
Cash flow hedge (losses) expected to be reclassified into earnings within twelve months			$ (220)

Equity Plans - Share Based Info

Equity Plans - Share Based Information, Restricted Stock Awards, and ESPP (Details) - $ / shares shares in Millions	6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	50
Restricted stock awards
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted stock award shares granted (in shares)	14	10
Weighted-average grant date fair value per share (in dollars per share)	$ 54	$ 71.31
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	16
Employee Stock Purchase Plan ("ESPP")
ESPP shares purchased (in shares)	3	2
Price of common shares issued (in dollars per share)	$ 52.45	$ 65.94

Equity Plans - Stock-based comp

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022	Sep. 01, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 133	$ 120	$ 259	$ 231
Equity Plans, Additional Disclosures
Total unrecognized compensation costs related to non-vested awards expected to be recognized	1,430		$ 1,430
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)			1 year 4 months 24 days
Equity plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Expense capitalized and remained in inventory	92		$ 92		$ 48
Restricted stock awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	116	104	225	200
Employee Stock Purchase Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	17	16	34	30
Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	0	0	0	1
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	59	45	112	83
Cost of goods sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	40	45	76	88
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	36	30	73	65
Restructure
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ (2)	$ 0	$ (2)	$ (5)

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022	Sep. 01, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 3,693	$ 7,786	$ 7,778	$ 15,473
Consideration Payable to Customers
Estimated consideration payable to customers for pricing adjustments and returns	605		605		$ 1,260
Proceeds from Insurance Settlement
Proceeds from Insurance Settlement	120
Business Interruption Recovered in Q2-23
Proceeds from Insurance Settlement
Proceeds from Insurance Settlement	114
DRAM
Disaggregation of Revenue [Line Items]
Revenue	2,722	5,719	5,551	11,306
NAND
Disaggregation of Revenue [Line Items]
Revenue	885	1,957	1,988	3,835
Other (primarily NOR)
Disaggregation of Revenue [Line Items]
Revenue	$ 86	$ 110	$ 239	$ 332

Restructure and Asset Impairm_3

Restructure and Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Employee severance	$ 80	$ 0	$ 93	$ 0
Asset impairments and other asset-related costs	8	5	8	59
Other Restructuring Costs	(2)	0	(2)	(16)
Restructure and asset impairments	86	$ 5	99	$ 43
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	160		160
Costs incurred and charged to expense	86		99
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructure liability as of September 1, 2022			0
Costs incurred and charged to expense			93
Costs paid or otherwise settled			(37)
Restructure liability as of March 2, 2023	$ 56		$ 56
Forecast
Restructuring Cost and Reserve [Line Items]
Restructuring, Expected Headcount Reduction (percentage)					15%

Other Non-Operating Income (E_3

Other Non-Operating Income (Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022
Other Nonoperating Income (Expense) [Abstract]
Gain (loss) on investments	$ (2)	$ 3	$ (11)	$ 13
Gain (loss) on debt repurchases	0	0	0	(83)
Other	4	3	9	1
Other non-operating income (expense), net	$ 2	$ 6	$ (2)	$ (69)

Income Taxes - Income (loss) be

Income Taxes - Income (loss) before Taxes and Other Items (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022	Mar. 02, 2023	Mar. 03, 2022
Income Tax Disclosure [Abstract]
Income (loss) before taxes	$ (2,271)	$ 2,509	$ (2,447)	$ 5,030
Income tax (provision) benefit	$ (54)	$ (255)	$ (62)	$ (474)
Effective tax rate	(2.40%)	10.20%	(2.50%)	9.40%
Tax benefit from incentive arrangements		$ 304		$ 594
Tax benefit per diluted share from incentive arrangements		$ 0.27		$ 0.53

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended				6 Months Ended
	Mar. 02, 2023	Dec. 01, 2022	Mar. 03, 2022	Dec. 02, 2021	Mar. 02, 2023	Mar. 03, 2022
Earnings Per Share Reconciliation
Net income (loss) - Basic	$ (2,312)	$ (195)	$ 2,263	$ 2,306	$ (2,507)	$ 4,569
Net income (loss) - Diluted	$ (2,312)		$ 2,263		$ (2,507)	$ 4,569
Weighted Average Number of Shares Outstanding Reconciliation
Weighted-average common shares outstanding – Basic	1,091		1,119		1,091	1,119
Dilutive effect of equity plans	0		11		0	11
Weighted-average common shares outstanding – Diluted	1,091		1,130		1,091	1,130
Basic (in dollars per share)	$ (2.12)		$ 2.02		$ (2.30)	$ 4.08
Diluted (in dollars per share)	$ (2.12)		$ 2		$ (2.30)	$ 4.04
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	33		2		34	2

Segment and Other Information_2

Segment and Other Information (Details) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2023 USD ($)	Mar. 03, 2022 USD ($)	Mar. 02, 2023 USD ($) segment	Mar. 03, 2022 USD ($)
Reportable Segments
Number of reportable segments | segment			4
Net sales
Revenue	$ 3,693	$ 7,786	$ 7,778	$ 15,473
Unallocated
Provision to write-down inventories to net realizable value	(1,430)		(1,430)	0
Stock-based compensation	(133)	(120)	(259)	(231)
Restructure and asset impairments	(86)	(5)	(99)	(43)
Operating income (loss)	(2,303)	2,546	(2,512)	5,177
Operating Segments
Unallocated
Operating income (loss)	(647)	2,750	(712)	5,475
Unallocated
Unallocated
Provision to write-down inventories to net realizable value	(1,430)	0	(1,430)	0
Stock-based compensation	(136)	(119)	(262)	(235)
Restructure and asset impairments	(86)	(5)	(99)	(43)
Other	(4)	(80)	(9)	(20)
Operating income (loss)	(1,656)	(204)	(1,800)	(298)
CNBU
Net sales
Revenue	1,375	3,461	3,121	6,867
CNBU | Operating Segments
Unallocated
Operating income (loss)	(35)	1,562	155	3,086
MBU
Net sales
Revenue	945	1,875	1,600	3,782
MBU | Operating Segments
Unallocated
Operating income (loss)	(344)	588	(539)	1,212
EBU
Net sales
Revenue	865	1,277	1,865	2,497
EBU | Operating Segments
Unallocated
Operating income (loss)	88	421	282	843
SBU
Net sales
Revenue	507	1,171	1,187	2,321
SBU | Operating Segments
Unallocated
Operating income (loss)	(357)	178	(614)	330
All Other
Net sales
Revenue	1	2	5	6
All Other | Operating Segments
Unallocated
Operating income (loss)	$ 1	$ 1	$ 4	$ 4

Certain Concentrations (Details

Certain Concentrations (Details) - Revenue from Contract with Customer - Product Concentration Risk	6 Months Ended
	Mar. 02, 2023	Mar. 03, 2022
Automotive, industrial, and consumer
Concentration Risk [Line Items]
Concentration Risk, Percentage	25%	15%
Enterprise and cloud server
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	20%
Client and graphics
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	20%
Mobile
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	25%
SSDs and other storage
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%	15%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended
	Mar. 28, 2023	Mar. 10, 2023	Mar. 02, 2023	Dec. 01, 2022	Mar. 03, 2022
Subsequent Event [Line Items]
Proceeds from Insurance Settlement			$ 120
Cash dividends declared (per share)			$ 0.115	$ 0.115	$ 0.10
Subsequent Event
Subsequent Event [Line Items]
Proceeds from Insurance Settlement		$ 110
Cash dividends declared (per share)	$ 0.115
Dividends Payable, Date to be Paid	Apr. 25, 2023
Dividends Payable, Date of Record	Apr. 10, 2023
Subsequent Event | Business Interruption Recovered in Q3-23
Subsequent Event [Line Items]
Proceeds from Insurance Settlement		$ 70